Sika AG

“Sika is among the highest-quality specialty chemical franchises globally — a specification-driven compounder with a widening moat, a 50-year M&A track record, and secular construction tailwinds; the MBCC-induced leverage and ROIC compression are cyclical, not structural, and at 17.9x forward earnings the stock offers a credible 10-12% annual return path with low probability of permanent capital loss, making it a compelling long-term accumulation opportunity even if not a deep-value bargain.”